The House Dust Mite Allergy Market is driven by rising cases of respiratory allergies

House dust mites are microscopic insects found in homes worldwide. They feed on dead human skin cells and flourish in warm and humid indoor environments. Exposure to house dust mites and their faeces and fragments can trigger an allergic reaction in sensitized individuals through airborne inhalation. This leads to allergic respiratory symptoms like sneezing, runny nose, itchy or watery eyes, nasal congestion, wheezing and asthma attacks. With changing lifestyles and increased time spent indoors, the prevalence of house dust mite allergy and associated respiratory issues has risen substantially in recent decades. According to research, house dust mites are one of the most common indoor allergens and a leading cause of asthma worldwide.

The global House Dust Mite Allergy Market caters to this growing patient pool suffering from house dust mite induced respiratory allergies. Key products available include antihistamines, decongestants, corticosteroid medications and immunotherapy vaccines. Antihistamines are the most common over-the-counter treatment for relieving sneezing, itching and other mild symptoms. Severe cases may require prescription-strength antihistamines, nasal corticosteroid sprays, nasal decongestants or leukotriene modifiers. Immunotherapy involves administering gradually increasing doses of house dust mite allergen extracts to induce tolerance in sensitized individuals and provide long term symptom relief.

Get More Insights on- House Dust Mite Allergy Market